Division of Infectious Diseases and Immunology Research

At NYU Langone’s Division of Infectious Diseases and Immunology, we believe that research is the engine that drives new medical advances to protect and restore public health locally and globally. Research is an important part of our mission, and our goal is to translate scientific research into innovative ways to prevent, diagnose, and treat infectious diseases.
Our research activities cover the entire span of biomedical discovery—from preclinical laboratory research using animal models, to clinical studies and clinical trials that translate into clinical practice. We also conduct research on healthcare policy, education, and behavior.
We are dedicated to training the next generation of research leaders in the field of infectious diseases and immunology. Important research initiatives within our division include the Vaccine Center, NYU Langone Molecular Outbreak Program, Special Pathogens Program at NYC Health + Hospitals/Bellevue, and hepatitis C elimination studies, as well as research on Staphylococcus aureus bacteria, hepatitis B, influenza, universal flu vaccine, flaviviruses, and yellow fever virus vaccines.
Core Faculty Investigators
Benjamin J. Eckhardt, MD
Assistant Professor, Department of Medicine
Lead Investigator, Hepatitis C Elimination Studies
Ramin Herati, MD
Assistant Professor, Department of Medicine
Mark J. Mulligan, MD
Director, Division of Infectious Diseases and Immunology
Director, Vaccine Center
The Thomas S. Murphy Sr. Professor, Department of Medicine
Vanessa N. Raabe, MD
Assistant Professor, Department of Medicine
Bo Shopsin, MD, PhD
Director, Molecular Epidemiology
Program Director, NYU Langone Molecular Outbreak Program
The Saul J. Farber Assistant Professor of Medicine, Department of Medicine
Assistant Professor, Department of Microbiology
Scott A. Weisenberg, MD
Medical Director, NYU Langone Infectious Disease Associates
Medical Director, Travel Medicine Program
Clinical Associate Professor, Department of Medicine
Faculty Publications
Our faculty publish their research in leading peer-reviewed journals. Learn more about their recent publications.
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
NPJ vaccines. 2023 Dec 01; 8:?-?
Immune response, phenotyping and molecular graft surveillance in kidney transplant recipients following severe acute respiratory syndrome coronavirus 2 vaccination
Transplant infectious disease. 2023 Sep 14; e14122
Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
Drug and alcohol dependence reports. 2023 Sep ; 8:100178
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
Vaccine. 2023 Aug 14; 41:5296-5303
"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City
Harm reduction journal. 2023 Jul 27; 20:95
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
NPJ vaccines. 2023 Jul 11; 8:98
Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data
MBio. 2023 Jun 30; e0104623
Vaccine Equity: Lessons Learned Exploring Facilitators and Barriers to COVID-19 Vaccination in Urban Black Communities
Journal of racial & ethnic health disparities. 2023 Jun 30;